Clinical Trials List
2006-11-01 - 2008-05-31
Phase III
Terminated5
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Shu-Min Lin Division of Thoracic Medicine
- Chun-Hua Wang Division of Thoracic Medicine
- Horng-Chyuan Lin Division of Thoracic Medicine
- 黃建達 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 吳惠東 Division of Thoracic Medicine
- 廖唯昱 Division of Thoracic Medicine
- Chong-Jen Yu Division of Thoracic Medicine
- 陳冠宇 Division of Thoracic Medicine
- 鄭之勛 Division of Thoracic Medicine
- 李佩玲 Division of Thoracic Medicine
- Shih-Chi Ku Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 蕭光明 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- TSUNG -YING YANG Division of Thoracic Medicine
- 蔡慶宏 Division of Thoracic Medicine
- 張開明 Division of Thoracic Medicine
- 王振宇 Division of Thoracic Medicine
- 沈光漢 Division of Thoracic Medicine
- 覃俊士 Division of Thoracic Medicine
- Chieh-Liang Wu Division of Thoracic Medicine
- Ming -Cheng Chan Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 游騰仁 Division of Thoracic Medicine
- 林群堯 Division of Thoracic Medicine
- 花仲涇 Division of Thoracic Medicine
- 于鍾傑 Division of Thoracic Medicine
- 姜伯穎 Division of Thoracic Medicine
- 朱建民 Division of Thoracic Medicine
- 謝文斌 Division of Thoracic Medicine
- 吳黃平 Division of Thoracic Medicine
- 曾若琦 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
100 participants
-
Global
1440 participants
